Clinical Trial Update: Phase IV Study of Qsymia in Obese Patients [Phase 4]

View source ↗

Summary

Phase IV trial update for Qsymia in obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Qsymia (phentermine/topiramate)

Snippet

Sponsor: Alvogen Korea | Conditions: Obesity | Phase 4 | Status: COMPLETED